Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)

J Totte; Jill de Wit; L Pardo; F Schuren; M Doorn; Suzanne Pasmans

doi:10.1186/s13063-017-2118-x

Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)

J Totte, Jill de Wit, L Pardo, F Schuren, M Doorn, Suzanne Pasmans

Research output: Contribution to journal › Article › Academic › peer-review

37 Citations (Scopus)

7 Downloads (Pure)

Original language	English
Article number	404
Journal	Trials
Volume	18
DOIs	https://doi.org/10.1186/s13063-017-2118-x
Publication status	Published - 2017

Access to Document

10.1186/s13063-017-2118-x

REPUB_101715-OA.pdfFinal published version, 718 KB

http://hdl.handle.net/1765/101715

Cite this

@article{c5aabefbccd747399d3611503ac508c5,

title = "Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)",

author = "J Totte and {de Wit}, Jill and L Pardo and F Schuren and M Doorn and Suzanne Pasmans",

year = "2017",

doi = "10.1186/s13063-017-2118-x",

language = "English",

volume = "18",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial)

AU - Totte, J

AU - de Wit, Jill

AU - Pardo, L

AU - Schuren, F

AU - Doorn, M

AU - Pasmans, Suzanne

PY - 2017

Y1 - 2017

U2 - 10.1186/s13063-017-2118-x

DO - 10.1186/s13063-017-2118-x

M3 - Article

SN - 1745-6215

VL - 18

JO - Trials

JF - Trials

M1 - 404

ER -